Search research articles
Contact Us
Filters
Showing results (41-50 of 50) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 50 results.
Brain : a Journal of Neurology
|
December 1, 1995
Primary writing tremor
P G Bain, L J Findley, T C Britton, et al.
Journal of Neurology
|
April 1, 1992
Primary orthostatic tremor: further observations in six cases
T C Britton, P D Thompson, W van der Kamp, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 26, 1999
Structure-activity relationships of a series of benzothiophene-derived NPY Y1 antagonists: optimization of the C-2 side chain
T C Britton, P G Spinazze, P A Hipskind, et al.
Brain : a Journal of Neurology
|
June 1, 1996
Tremor associated with benign IgM paraproteinaemic neuropathy
P G Bain, T C Britton, I H Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 14, 1999
Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists
H Zarrinmayeh, D M Zimmerman, B E Cantrell, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Structure-activity relationships of a series of 1-substituted-4-methylbenzimidazole neuropeptide Y-1 receptor antagonists
D M Zimmerman, B E Cantrell, E C Smith, et al.
Journal of Medicinal Chemistry
|
July 21, 1998
Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonists
H Zarrinmayeh, A M Nunes, P L Ornstein, et al.
Journal of Medicinal Chemistry
|
November 26, 1997
Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists
P A Hipskind, K L Lobb, J A Nixon, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 4, 2010
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
S J Wilson, D J Nutt, C Alford, et al.
Journal of Neurochemistry
|
January 9, 2001
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
H F Dovey, V John, J P Anderson, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 50) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 50 results.
Brain : a Journal of Neurology
|
December 1, 1995
Primary writing tremor
P G Bain, L J Findley, T C Britton, et al.
Journal of Neurology
|
April 1, 1992
Primary orthostatic tremor: further observations in six cases
T C Britton, P D Thompson, W van der Kamp, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 26, 1999
Structure-activity relationships of a series of benzothiophene-derived NPY Y1 antagonists: optimization of the C-2 side chain
T C Britton, P G Spinazze, P A Hipskind, et al.
Brain : a Journal of Neurology
|
June 1, 1996
Tremor associated with benign IgM paraproteinaemic neuropathy
P G Bain, T C Britton, I H Jenkins, et al.
Bioorganic & Medicinal Chemistry Letters
|
April 14, 1999
Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists
H Zarrinmayeh, D M Zimmerman, B E Cantrell, et al.
Bioorganic & Medicinal Chemistry Letters
|
January 1, 1999
Structure-activity relationships of a series of 1-substituted-4-methylbenzimidazole neuropeptide Y-1 receptor antagonists
D M Zimmerman, B E Cantrell, E C Smith, et al.
Journal of Medicinal Chemistry
|
July 21, 1998
Synthesis and evaluation of a series of novel 2-[(4-chlorophenoxy)methyl]benzimidazoles as selective neuropeptide Y Y1 receptor antagonists
H Zarrinmayeh, A M Nunes, P L Ornstein, et al.
Journal of Medicinal Chemistry
|
November 26, 1997
Potent and selective 1,2,3-trisubstituted indole NPY Y-1 antagonists
P A Hipskind, K L Lobb, J A Nixon, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 4, 2010
British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders
S J Wilson, D J Nutt, C Alford, et al.
Journal of Neurochemistry
|
January 9, 2001
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain
H F Dovey, V John, J P Anderson, et al.
Page
of 5